Société Melinta Therapeutics, Inc. Other OTC
Actions
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 48 | 03/08/20 | |
Susan Blum
DFI | Director of Finance/CFO | 52 | 01/01/16 |
Compliance Officer | 45 | - | |
Jisoo Park
PRN | Corporate Officer/Principal | - | 06/07/21 |
Kristen Allgor
HRO | Human Resources Officer | - | 16/11/20 |
John Harlow
PRN | Corporate Officer/Principal | - | 30/03/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 20/04/20 |
Director/Board Member | - | 20/04/20 | |
Director/Board Member | - | 20/04/20 | |
Compliance Officer | 45 | - | |
Chief Executive Officer | 48 | 03/08/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 13 750 691 | 13 578 334 ( 98,75 %) | 0 | 98,75 % |
Coordonnées société
Melinta Therapeutics, Inc.
389 Interpace Parkway Suite 450
07054, Parsippany
+908-617-1300
http://melinta.com![Adresse Melinta Therapeutics, Inc.](https://cdn.zonebourse.com/static/address/55126386.png)
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+15,20% | 121 Md | |
+19,67% | 113 Md | |
+18,95% | 26,02 Md | |
-23,86% | 19,39 Md | |
-19,03% | 15,91 Md | |
-20,90% | 15,09 Md | |
-46,14% | 15,06 Md | |
+63,85% | 14,93 Md | |
+4,49% | 13,85 Md |